2017 Tuberculosis Drug Discovery and Development Gordon Research Conference and Gordon Research Seminar

项目摘要 该申请寻求对2017年结核病（TB）药物发现和开发戈登的部分支持 研究会议（GRC）和戈登研究研讨会（GRS）将于2015年12月25日至26日在意大利的卢卡（巴尔加）举行。 2017年6月24日至30日。这个两年一度的活动是最重要的全球会议，汇集了研究人员 从学术界和工业界来关注这个问题。结核病的治疗仍然是一个持续的挑战 特别是随着耐药性问题的日益严重。新的治疗方法可以大大改善 药物敏感性和耐药性疾病的治疗结果以及具有新作用模式的化合物 正因如此，积极寻求。结核病药物发现和开发是一个非常活跃的领域， 研究，并越来越多地吸引不同背景的研究人员，包括微生物学， 化学、药理学、医学和临床研究。2017年关于结核病药物发现的GRC和GRS 发展将为新的调查人员提供一个机会，使他们了解实地的挑战， 经验丰富的研究人员在一个特别关键的时刻讨论最新的发现。

Project Abstract This application seeks partial support for the 2017 Tuberculosis (TB) Drug Discovery & Development Gordon Research Conference (GRC) and Gordon Research Seminar (GRS) to be held in Lucca (Barga), Italy from June 24th-30th, 2017. This biennial event is the most important global conference bringing together researchers from both academia and industry to focus on this problem. Treatment of TB remains a continuing challenge particularly with the increasing problem of drug resistance. New treatments could dramatically improve the results of therapy of both drug-sensitive and drug-resistant disease and compounds with new modes-of-action are being actively sought for this reason. TB Drug Discovery & Development is an extremely vigorous area of research and is increasingly attracting investigators with diverse backgrounds, including microbiology, chemistry, pharmacology, medicine and clinical research. The 2017 GRC and GRS on TB Drug Discovery & Development will provide an opportunity for new investigators to understand the challenges in the field and for experienced researchers to discuss the latest findings at a particularly critical juncture.